Redmile Group
SEC-registered investment adviser.
- Website
- HTTP://WWW.REDMILEGROUP.COM
- HQ
- CA
Limited data: profile built from SEC filings only.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Growth, Series B, Series A |
| Sectors | Not stated | Not enough dated deals | Biotech, Healthtech, Medical devices, Life sciences and research tools |
| Regions | Not stated | Not enough dated deals | CA, MA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2008 | 1 | Biotech, Healthtech, Life sciences and research tools |
| 2011 | 1 | Advanced materials, Biotech, Medical devices |
| 2012 | 2 | Healthtech, Biotech, Medical devices |
| 2013 | 4 | Healthtech, Biotech, Medical devices |
| 2014 | 10 | Biotech, Healthtech, Life sciences and research tools |
| 2015 | 10 | Biotech, Healthtech, Medical devices |
| 2016 | 9 | Healthtech, Biotech, Life sciences and research tools |
| 2017 | 11 | Healthtech, Biotech, Medical devices |
| 2018 | 14 | Biotech, Healthtech, Life sciences and research tools |
| 2019 | 15 | Biotech, Healthtech, Digital health |
| 2020 | 13 | Biotech, Healthtech, Life sciences and research tools |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2012 | 0 | 0 | 0 | 1 | 1 |
| 2013 | 0 | 0 | 1 | 0 | 2 |
| 2014 | 0 | 0 | 0 | 4 | 5 |
| 2015 | 0 | 0 | 1 | 4 | 5 |
| 2016 | 0 | 0 | 1 | 1 | 4 |
| 2017 | 0 | 0 | 1 | 4 | 5 |
| 2018 | 0 | 0 | 2 | 5 | 6 |
| 2019 | 0 | 0 | 2 | 7 | 5 |
| 2020 | 0 | 1 | 2 | 2 | 4 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Redmile Growth Investments I, L.P. | 2021 | $122M to $156.84M (Form D and SEC adviser filing) | Follow-ons only |
| RedCo II Offshore Fund, L.P. | 2021 | $579.02M (Form D) | Follow-ons only |
| RedCo II, L.P. | 2021 | $31.4M (Form D) | Follow-ons only |
| Redmile Biopharma Investments III, L.P. | 2020 | $500.24M (Form D) | Follow-ons only |
03 · People across funds
- Amrit Nagpal
Redmile Growth Investments I, L.P. (Named on Form D); RedCo II Offshore Fund, L.P. (Named on Form D); RedCo II, L.P. (Named on Form D); Redmile Biopharma Investments III, L.P. (Named on Form D)
- Jeremy Green
Redmile Growth Investments I, L.P. (Named on Form D); RedCo II Offshore Fund, L.P. (Named on Form D); RedCo II, L.P. (Named on Form D); Redmile Biopharma Investments III, L.P. (Named on Form D)
- Mike Lee
Redmile Growth Investments I, L.P. (Named on Form D); RedCo II Offshore Fund, L.P. (Named on Form D); RedCo II, L.P. (Named on Form D); Redmile Biopharma Investments III, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026